SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Eli Lilly
LLY 884.54+2.9%Apr 25 9:30 AM EDT

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: Moonray6/1/2021 9:27:56 PM
   of 634
 
Distribution of Eli Lilly COVID-19 therapy
paused in 8 states over variant concerns

For now, the FDA recommends using
Regeneron's antibody cocktail instead.

Federal health authorities have paused distribution
of Eli Lilly's monoclonal antibody cocktail in eight
tates over COVID-19 variant efficacy concerns.

The COVID-19 treatment will halt distribution in
Arizona,
alifornia,
Florida,
llinois,
Indiana,
Massachusetts,
Oregon and
Washington
"until further notice" due to variants' elevation in those
states, the U.S. Department of Health and Human
Services and Assistant Secretary for Preparedness
and Response announced in a bulletin this week.

More at: abcnews.go.com

o~~~ O
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext